SNDL (SNDL) Competitors $2.53 +0.06 (+2.43%) Closing price 08/27/2025 04:00 PM EasternExtended Trading$2.53 0.00 (0.00%) As of 05:15 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock SNDL vs. ACB, CGC, CRON, OGI, TLRY, AGIO, IDYA, DNLI, OCUL, and HRMYShould you be buying SNDL stock or one of its competitors? The main competitors of SNDL include Aurora Cannabis (ACB), Canopy Growth (CGC), Cronos Group (CRON), Organigram Global (OGI), Tilray Brands (TLRY), Agios Pharmaceuticals (AGIO), IDEAYA Biosciences (IDYA), Denali Therapeutics (DNLI), Ocular Therapeutix (OCUL), and Harmony Biosciences (HRMY). These companies are all part of the "pharmaceutical products" industry. SNDL vs. Its Competitors Aurora Cannabis Canopy Growth Cronos Group Organigram Global Tilray Brands Agios Pharmaceuticals IDEAYA Biosciences Denali Therapeutics Ocular Therapeutix Harmony Biosciences Aurora Cannabis (NASDAQ:ACB) and SNDL (NASDAQ:SNDL) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, dividends, risk, institutional ownership, valuation, analyst recommendations, earnings and media sentiment. Do analysts rate ACB or SNDL? SNDL has a consensus price target of $4.00, suggesting a potential upside of 58.10%. Given SNDL's higher possible upside, analysts clearly believe SNDL is more favorable than Aurora Cannabis.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aurora Cannabis 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 2 Strong Buy rating(s) 3.00SNDL 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is ACB or SNDL more profitable? Aurora Cannabis has a net margin of -5.66% compared to SNDL's net margin of -10.38%. Aurora Cannabis' return on equity of -1.49% beat SNDL's return on equity.Company Net Margins Return on Equity Return on Assets Aurora Cannabis-5.66% -1.49% -1.06% SNDL -10.38%-8.58%-7.23% Which has better valuation & earnings, ACB or SNDL? Aurora Cannabis has higher earnings, but lower revenue than SNDL. Aurora Cannabis is trading at a lower price-to-earnings ratio than SNDL, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAurora Cannabis$246.72M1.22$1.63M-$0.19-28.05SNDL$671.81M0.99-$69.18M-$0.27-9.37 Does the media favor ACB or SNDL? In the previous week, SNDL had 1 more articles in the media than Aurora Cannabis. MarketBeat recorded 4 mentions for SNDL and 3 mentions for Aurora Cannabis. Aurora Cannabis' average media sentiment score of 1.19 beat SNDL's score of 0.54 indicating that Aurora Cannabis is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Aurora Cannabis 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SNDL 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more volatility & risk, ACB or SNDL? Aurora Cannabis has a beta of 1.84, meaning that its stock price is 84% more volatile than the S&P 500. Comparatively, SNDL has a beta of 3.57, meaning that its stock price is 257% more volatile than the S&P 500. Do insiders and institutionals have more ownership in ACB or SNDL? 47.6% of Aurora Cannabis shares are held by institutional investors. 0.0% of Aurora Cannabis shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. SummaryAurora Cannabis beats SNDL on 12 of the 17 factors compared between the two stocks. Get SNDL News Delivered to You Automatically Sign up to receive the latest news and ratings for SNDL and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SNDL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SNDL vs. The Competition Export to ExcelMetricSNDLMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$649.06M$10.72B$5.76B$9.78BDividend YieldN/A1.86%3.95%4.02%P/E Ratio-9.3721.2030.8026.37Price / Sales0.9931.88463.59121.32Price / CashN/A24.9437.7659.36Price / Book0.853.5010.106.62Net Income-$69.18M$210.11M$3.26B$265.42M7 Day Performance12.95%4.70%2.78%3.08%1 Month Performance68.67%11.78%3.94%0.77%1 Year Performance31.77%-6.50%42.93%22.97% SNDL Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SNDLSNDL1.9152 of 5 stars$2.53+2.4%$4.00+58.1%+29.1%$649.06M$671.81M-9.372,516ACBAurora Cannabis0.944 of 5 stars$5.12+0.8%N/A-13.6%$289.02M$246.72M-26.951,130Positive NewsCGCCanopy Growth0.2899 of 5 stars$1.37+5.4%N/A-72.9%$328.59M$225.65M-0.453,150High Trading VolumeCRONCronos Group0.7839 of 5 stars$2.53+6.8%N/A+16.4%$969.09M$117.61M50.60450Trending NewsOGIOrganigram Global0.3976 of 5 stars$1.53+7.0%N/A-8.7%$205.07M$117.47M30.61860TLRYTilray Brands2.2259 of 5 stars$1.14+10.7%$1.92+68.1%-21.7%$1.25B$821.31M-0.492,842Trending NewsAnalyst ForecastOptions VolumeAGIOAgios Pharmaceuticals4.3754 of 5 stars$37.45+1.2%$56.33+50.4%-16.6%$2.18B$40.88M3.40390Positive NewsIDYAIDEAYA Biosciences4.4489 of 5 stars$24.75+1.7%$48.09+94.3%-36.5%$2.17B$7M-6.5380News CoveragePositive NewsDNLIDenali Therapeutics4.3188 of 5 stars$14.82+0.8%$33.62+126.8%-37.5%$2.17B$330.53M-5.29430Positive NewsOCULOcular Therapeutix4.1767 of 5 stars$12.31-2.5%$17.20+39.7%+36.3%$2.14B$63.72M-9.62230Insider TradeHRMYHarmony Biosciences4.7176 of 5 stars$36.41-1.2%$51.00+40.1%+6.8%$2.09B$714.73M11.75200Positive News Related Companies and Tools Related Companies Aurora Cannabis Alternatives Canopy Growth Alternatives Cronos Group Alternatives Organigram Global Alternatives Tilray Brands Alternatives Agios Pharmaceuticals Alternatives IDEAYA Biosciences Alternatives Denali Therapeutics Alternatives Ocular Therapeutix Alternatives Harmony Biosciences Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SNDL) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredNVIDIA's Worst Nightmare?$2 TRILLION Quantum Gold Rush While everyone fights over expensive AI stocks... McKinsey just revealed the ...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredSmall Washington, DC Group Could Crash US StocksNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredI’d rather trade news like this than gamble on hypeReal traders are watching Nvidia’s next move—after U.S. approval to resume chip sales to China. This reversal ...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SNDL Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share SNDL With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access